Trade Neumora Therapeutics Inc - NMRA CFD
What is Neumora Therapeutics Inc (NMRA)?
Neumora Therapeutics Inc is a biotechnology company dedicated to the discovery and development of treatments for neuropsychiatric and neurological disorders. The company applies advanced scientific approaches to identify novel targets and develop therapeutic candidates aimed at addressing conditions such as depression, anxiety, and cognitive impairments. Neumora Therapeutics integrates genomics, molecular biology, and pharmacology in its research efforts to understand disease mechanisms and improve treatment outcomes. The company engages in preclinical and clinical development activities, collaborating with academic and industry partners to advance its pipeline. Neumora operates within the biopharmaceutical sector, focusing on innovative solutions for brain health.
Neumora Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by market participation, with Neumora Therapeutics Inc valued at $2.05. It has fluctuated from $1.94 to $2.08 throughout the session, showing a daily change of +1.5464%.
FAQ: Neumora Therapeutics Inc (NMRA)
What is the current price of NMRA stock?
The current trading price is $2.05.
Does NMRA pay dividends?
Neumora Therapeutics Inc does not pay dividends.
Does NMRA have a formal corporate presence or regional headquarters in the UAE?
The company does not have an official regional office or subsidiary in the UAE and operates through partners.
What is NMRA best known for?
It is most famous for developing treatments for central nervous system disorders.
What assets are typically shown together with NMRA?
Commonly shown alongside NMRA: Invesco California AMT-Free Municipal Bond ETF, Renaissance IPO ETF, Capcom Co Ltd
Latest shares articles



